Head of Europe, Sandoz
Passion for success through work drives Rebecca Guntern Flückiger. As vice president of medicines for Europe, she strongly advocates for sustainable healthcare in Europe and takes the position that access to healthcare should be a right, not a privilege.
“The value of the generics and biosimilar industry to both patients and society is often lost in the public debate surrounding medicine prices. Policymakers must actively pursue a social agenda that recognizes the full role and value of off-patent medicines. This requires a shift in perception away from cost to contribution and value to societies and healthcare systems.”